HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kirsten M Timms Selected Research

Messenger RNA (mRNA)

1/2018Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kirsten M Timms Research Topics

Disease

22Neoplasms (Cancer)
02/2024 - 01/2010
13Ovarian Neoplasms (Ovarian Cancer)
02/2024 - 08/2010
8Triple Negative Breast Neoplasms
11/2023 - 06/2015
6Breast Neoplasms (Breast Cancer)
11/2023 - 06/2015
5Genomic Instability
11/2023 - 01/2016
4Carcinoma (Carcinomatosis)
02/2024 - 01/2020
3Pathologic Complete Response
11/2023 - 01/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2024 - 01/2021
1Neoplasm Metastasis (Metastasis)
01/2024
1Microsatellite Instability
01/2024
1Heart Failure
01/2023
1Leukopenia
01/2023
1Neutropenia
01/2023
1Thrombocytopenia (Thrombopenia)
01/2023
1Sepsis (Septicemia)
01/2023
1Acute Kidney Injury (Acute Renal Failure)
01/2023
1Carcinogenesis
12/2021
1Endometrial Neoplasms (Endometrial Cancer)
01/2021
1Adenocarcinoma
11/2018
1Disease Progression
10/2018
1DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
03/2017
1Residual Neoplasm
01/2016
1Hypersensitivity (Allergy)
09/2015
1Ovarian Epithelial Carcinoma
06/2012
1Knee Osteoarthritis
06/2008
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
03/2004

Drug/Important Bio-Agent (IBA)

15PlatinumIBA
11/2023 - 08/2010
11DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2010
8Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2023 - 08/2010
8Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2015
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2023 - 10/2018
4olaparibIBA
12/2021 - 08/2017
4Carboplatin (JM8)FDA LinkGeneric
01/2018 - 06/2015
2Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2016
2GemcitabineFDA Link
01/2017 - 01/2016
2iniparibIBA
01/2017 - 01/2016
1Hematoxylin (Haematoxylon)IBA
02/2024
1ElementsIBA
02/2024
1Eosine Yellowish-(YS) (Eosin)IBA
02/2024
1AndrogensIBA
01/2024
1SaltsIBA
01/2024
1Estrogen ReceptorsIBA
11/2023
1veliparibIBA
01/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
11/2022
1Adenosine Diphosphate (ADP)IBA
11/2022
1Ataxia Telangiectasia Mutated ProteinsIBA
01/2020
1ABT-767IBA
10/2018
1taxaneIBA
04/2018
1AnthracyclinesIBA
04/2018
1Hormones (Hormone)IBA
04/2018
1Trinitrotoluene (TNT)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1MutagensIBA
09/2015
1Proteins (Proteins, Gene)FDA Link
06/2015
1eribulinFDA Link
06/2015
1Poly (ADP-Ribose) Polymerase-1IBA
08/2010
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2008
1ApolipoproteinsIBA
03/2004
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2004
1LDL Receptors (LDL Receptor)IBA
03/2004

Therapy/Procedure

12Therapeutics
01/2024 - 06/2012
9Drug Therapy (Chemotherapy)
01/2023 - 06/2012
4Neoadjuvant Therapy
04/2018 - 06/2015